7. Marmor D. La contraception locale spermicide. Gynecol Obstet Fertil 2001; 29: 705–713.
8. Li W, Huang Z, Wu Y et al. Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women.//Contraception. 2013 Jun; 87(6):756-65. Epub 2012 Oct 22.
9. Serfaty D. Contraception in breastfeeding women: place for spermicides // J Gynecol Obstet Biol Reprod (Paris). 2015 Jan; 44(1):18–27. doi: 10.1016/j.jgyn.2014.07.001. Epub 2014 Oct 23 [PMID: 25443467].
10. Serfaty D. Contraception during perimenopause: The spermicides option // J Gynecol Obstet Hum Reprod. 2017 Mar;46(3):211–218. doi: 10.1016/j.jogoh.2016.10.007. Epub 2017 Jan 30. [PMID: 28403917].
11. Дикке Г. Б., Ерофеева Л. В. Современные особенности национальной контрацепции: информированность, применение и эффективность // Вопросы гинекологии, акушерства и перинатологии. 2014. № 1 (5). С. 63–71.
12. Хамошина М. Б., Маклецова С. А. Результаты социологического опроса россиян о знаниях по контрацепции (2015) // Status Praesens. Гинекология, акушерство, бесплодный брак. 2015. № 5 (28). С. 43–50.
13. Crosby, R., Sanders, S., Yarber, W. L., & Graham, C. A. (2003). Condom-use errors and problems. American Journal of Preventive Medicine, 24(4), 367–370. doi:10.1016/s0749-3797(03)00015-1.
1. Hipp LE, Kane Low L, van Anders SM. Exploring women’s postpartum sexuality: social, psychological, relational, and birth-related contextual factors. J Sex Med. 2012;9(9):2330–2341. doi:10.1111/j.1743–6109.2012.02804.x.
2. Ladomenou F, Moschandreas J, Kafatos A, et al. Protective effect of exclusive breastfeeding against infections during infancy: a prospective study. Archives of Disease in Childhood 2010;95:1004–1008.
3. Svanborg C, Agerstam H, Aronson A, Bjerkvig R, Düringer C, Fischer W, Gustafsson L, Hallgren O, Leijonhuvud I, Linse S, Mossberg AK, Nilsson H, Pettersson J, Svensson M. HAMLET kills tumor cells by an apoptosis-like mechanism-cellular, molecular, and therapeutic aspects. J Adv Cancer Res. 2003; 88:1-29.
4. Beth Skwarecki. Killing Bacteria, With a Little Help From Breast Milk Science.2013
https://www.sciencemag.org/news/2013/05/scienceshot-killing-bacteria-little-help-breast-milk.
5. Медицинские критерии приемлемости для использования методов контрацепции / ВОЗ. 5-е изд. 2015.
6. Merki-Feld GS, Imthurn B, Langner R, Seifert B, Gantenbein AR. Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days. J Headache Pain. 2015;16:522. doi:10.1186/s10194-015-0522-8.
7. Long ME, Faubion SS, MacLaughlin KL, Pruthi S, Casey PM. Contraception and hormonal management in the perimenopause. J Womens Health (Larchmt). 2015;24(1):3-10. doi:10.1089/jwh.2013.4544.
8. Клинические рекомендации (протокол лечения) от 02.10.2015 г. № 15-4/10/2-5804 «Менопаузальная гормонотерапия и сохранение здоровья женщин в зрелом возрасте». Российское общество акушеров-гинекологов.
9. Baldwin MK, Jensen JT. Contraception during the perimenopause. Maturitas. 2013;76(3):235–242. doi:10.1016/j.maturitas.2013.07.009.
10. Bitzer J. Overview of perimenopausal contraception. Climacteric. 2019;22(1):44–50. doi:10.1080/13697137.2018.1540566.
11. Shifren JL, Gass ML; NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014; 21(10):1038–1062. doi:10.1097/GME.0000000000000319.
12. Rebecca H. Allen, MD, MPH, and Carrie A. Cwiak, MD, MPH. Contraception for midlife women // Menopause, Vol. 23, No. 1, 2016.
13. Wildemeersch D. Safety and comfort of long-term continuous combined transdermal estrogen and intrauterine levonorgestrel administration for postmenopausal hormone substitution – a review. Gynecol Endocrinol 2016; 32:598–601.
14. Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Womens Ment Health 2005; 8:77.
15. Lenders CM, McElrath TF, Scholl TO. Nutrition in adolescent pregnancy. Curr Opin Pediatr 2000; 12:291.
16. Kingston D, Heaman M, Fell D, et al. Comparison of adolescent, young adult, and adult women’s maternity experiences and practices. Pediatrics 2012; 129:e1228.
17. Fraser AM, Brockert JE, Ward RH. Association of young maternal age with adverse reproductive outcomes. N Engl J Med 1995; 332:1113.
18. Olausson PM, Cnattingius S, Goldenberg RL. Determinants of poor pregnancy outcomes among teenagers in Sweden. Obstet Gynecol 1997; 89:451.
19. Rees JM, Lederman SA, Kiely JL. Birth weight associated with lowest neonatal mortality: infants of adolescent and adult mothers. Pediatrics 1996; 98:1161.
20. Phipps MG, Blume JD, DeMonner SM. Young maternal age associated with increased risk of postneonatal death. Obstet Gynecol 2002; 100:481.
21. Paranjothy S, Broughton H, Adappa R, Fone D. Teenage pregnancy: who suffers? Arch Dis Child 2009; 94:239.
22. Malabarey OT, Balayla J, Klam SL, et al. Pregnancies in young adolescent mothers: a population-based study on 37 million births. J Pediatr Adolesc Gynecol 2012; 25:98.
23. Ganchimeg T, Ota E, Morisaki N, et al. Pregnancy and childbirth outcomes among adolescent mothers: a World Health Organization multicountry study. BJOG 2014; 121 Suppl 1:40.
24. Traisrisilp K, Jaiprom J, Luewan S, Tongsong T. Pregnancy outcomes among mothers aged 15 years or less. J Obstet Gynaecol Res 2015; 41:1726.
25. Brosens I, Muter J, Gargett CE, et al. The impact of uterine immaturity on obstetrical syndromes during adolescence. Am J Obstet Gynecol 2017; 217:546.
26. Paranjothy S, Broughton H, Adappa R, Fone D. Teenage pregnancy: who suffers? Arch Dis Child 2009; 94:239.
27. Maynard RA. Kids having kids: economic costs and social consequences of teen pregnancy, Urban Institute Press, Washington, DC 1997.
28. Nord CW, Moore KA, Morrison DR, et al. Consequences of teen-age parenting. J Sch Health 1992; 62:310.
29. Wiemann CM, Agurcia CA, Berenson AB, et al. Pregnant adolescents: experiences and behaviors associated with physical assault by an intimate partner. Matern Child Health J 2000; 4:93.
30. Harrykissoon SD, Rickert VI, Wiemann CM. Prevalence and patterns of intimate partner violence among adolescent mothers during the postpartum period. Arch Pediatr Adolesc Med 2002; 156:325.
31. Moffitt TE, E-Risk Study Team. Teen-aged mothers in contemporary Britain. J Child Psychol Psychiatry 2002; 43:727.
32. Assini-Meytin LC, Green KM. Long-term consequences of adolescent parenthood among African-American urban youth: a propensity score matching approach. J Adolesc Health 2015; 56:529.
33. Udo IE, Lewis Lmft JB, Tobin JN, Ickovics JR. Intimate Partner Victimization and Health Risk Behaviors Among Pregnant Adolescents. Am J Public Health 2016; 106:1457.
34. Bennell K, White S, Crossley K. The oral contraceptive pill: a revolution for sportswomen?. Br J Sports Med. 1999;33(4):231–238. doi:10.1136/bjsm.33.4.231.
35. Schaumberg MA, Emmerton LM, Jenkins DG, Burton NW, Janse de Jonge XAK, Skinner TL. Use of Oral Contraceptives to Manipulate Menstruation in Young, Physically Active Women. Int J Sports Physiol Perform. 2018; 13(1):82–87. doi:10.1123/ijspp.2016–0689.
36. Bonnema RA, McNamara MC, Spencer AL. Contraception choices in women with underlying medical conditions. Am Fam Physician. 2010; 82(6):621–628.
37. Glasier A. Acceptability of contraception for men: a review. Contraception. 2010; 82:453–456.
38. Mullin E. Men will soon test a sperm-stopping gel for birth control. MIT Technology Review. December 20, 2017. Source Accessed November 26, 2018.
39. U.S. National Library of Medicine. ClinicalTrials.gov.
Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception. ClinicalTrials.gov Identifier: NCT03452111.
40. U.S. National Library of Medicine. ClinicalTrials.gov.
Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males (CCN005B). ClinicalTrials.gov Identifier: NCT02994602.
41. Ilani N, Roth MY, Amory JK, et al. A new combination of testosterone and nestorone transdermal gels for male hormonal contraception. J Clin Endocrinol Metab. 2012; 97:3476–3486.
42. Roth MY, Shih G, Ilani N, et al. Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial. Contraception. 2014; 90:407–412.